Wolters Kluwer N.V.: Share Buyback Transaction Details May

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
713
Wolters Kluwer N.V.: Share Buyback Transaction Details May 31 - June 6, 2018

Share Buyback Transaction Details May 31 - June 6, 2018

June 7, 2018 - Wolters Kluwer today reports that it has repurchased 178,041 of its own ordinary shares in the period from May 31, 2018 up to and including June 6, 2018 for €8.5 million and at an average share price of €47.75.

These share repurchases are part of the three-year share buyback program (2016-2018) originally announced on February 24, 2016. This buyback program includes repurchases made to offset annual incentive share issuance. The cumulative amounts repurchased under this three-year program are now as follows:

Share Buyback Program 2016-2018

Period Cumulative shares repurchased in period Total consideration (€ million) Average share price (€)
2018 To Date 5,419,039 234.2 43.22
2017 7,768,288 300.0 38.62
2016 5,826,473 199.7 34.28
Total 19,013,800 734.0 38.60

As stated on February 21, 2018, we intend to execute up to €400 million in share buybacks in 2018, including €200 million to mitigate the EPS dilution related to the sale of Corsearch and certain Swedish assets . In addition, following the completion of the sale of ProVation on March 9, 2018, we also intend to deploy these proceeds of this sale (€150 million) towards additional share repurchases in 2018 and 2019 to mitigate the expected EPS dilution.

Current repurchases are being executed under a third party mandate granted on May 9, 2018. Under this mandate, €100 million of share buybacks will be executed in the period from May 10, 2018, up to and including July 30, 2018.

Share repurchases are made within the limits of relevant laws and regulations, in particular Regulation (EU) 596/2014) and Wolters Kluwer's Articles of Association. Repurchased shares are added to and held as Treasury shares and will be used for capital reduction purposes or to meet obligations arising from share-based incentive plans.

Further information is available on our website:

About Wolters Kluwer Wolters Kluwer N.V. (AEX: WKL) is a global leader in information, software solutions, and services for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2017 annual revenues of €4.4 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our solutions and organization, visit www.wolterskluwer.com , follow us on Twitter , Facebook , LinkedIn , and YouTube .

Media Investors/Analysts
Annemarije Dérogée-Pikaar Meg Geldens
Corporate Communications Investor Relations
t + 31 172 641 470 t + 31 172 641 407
annemarije.pikaar@wolterskluwer.com ir@wolterskluwer.com
   

Forward-looking Statements and Other Important Legal Information This report contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall" and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This press release contains information which is to be made publicly available under Regulation (EU) 596/2014.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 10

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 10

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 17

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Magna5 Secures 39th Spot on Inc.'s Prestigious Rankings

Updated Category News Views 245

Magna5 Achieves Recognition in Inc. Rankings In a proud moment for the team, Magna5 has ranked No. 39 on the coveted Inc. Regionals: Northeast list. This annual evaluation highlights the fastest-growing private companies within this region, emphasizing the remarkable impact of independent small businesses in various sectors. The company’s recognition showcases its...

Continue Reading
Appian Shines as a Leader in Process Orchestration Assessment

Updated Category News Views 236

Appian Recognized as a Leader in Process Orchestration Appian has made headlines recently by being named a leader in a prominent assessment of process orchestration products. This recognition by Everest Group positions Appian at the forefront of innovations that empower businesses to enhance their operational workflows and increase efficiency. What Is Process...

Continue Reading
Financial Institutions Reports Strong EPS Beat, Price Target Held

Updated Category News Views 195

Analysis of Financial Institutions’ Recent Performance Recently, Financial Institutions (NASDAQ:FISI) received an Equal Weight rating from Stephens, reaffirming a price target of $28.50. The company delivered impressive financial results, with earnings per share (EPS) reported at $0.84 for GAAP and $0.82 for operating earnings. These figures exceeded both the company's...

Continue Reading
United Airlines Earnings Preview: Analyst Upgrades and Insights

Updated Category News Views 168

United Airlines Earnings Report Overview United Airlines Holdings, Inc. (NASDAQ: UAL) is on the brink of announcing its third-quarter earnings results. Investors and analysts alike are eagerly anticipating these numbers, especially as the company is projected to report a decrease in earnings per share compared to the previous year. Expected Earnings Decline Analysts...

Continue Reading
Ontex's Strategic Share Buyback Program Overview

Updated Category News Views 114

Ontex's Strategic Share Buyback Program Ontex is making headlines with its ongoing program to acquire treasury shares, which marks a significant move for the company. The decision to initiate this buyback was formally disclosed in accordance with the regulations established by the Belgian government. This proactive strategy is designed to enhance shareholder value and...

Continue Reading